CHMA News and Press, Chiasma Inc. From 12/02/20

Tredegar Corporation (TG +29% on declaring special dividend.Catabasis Pharmaceuticals (CATB) +25%.India Globalization Capital (IGC) +19%.Ashford Hospitality Trust (AHT) +14%.Mesoblast Limited (MESO) +12%.iBio (IBIO +12% after company was selected to produce ATB Therapeutic...

Today, we revisit Chiasma for the first time in over a year. This promising small-cap name recently posted some encouraging trial results and has seen a big recent insider purchase by its CEO. We revisited the investment thesis on Chiasma in the paragraphs below. For further...

Gainers: AnPac Bio-Medical Science (ANPC) +110%, Cocrystal Pharma (COCP) +56%, Renalytix AI (RNLX) +31%, Precigen (PGEN) +13%, Chiasma (CHMA) +11%.Losers: Hepion Pharmaceuticals (HEPA) -29%, Medigus (MDGS) -12%, Retractable Technologies (...

NEEDHAM, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful i...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe week ahead will see investors once again weigh the brightening prospects for COVID-19 vaccines against a surging pand...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. A ho...

NEEDHAM, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painf...

VAALCO Energy (EGY) +39% as it agrees to acquire Sasol's 27.8% working interest in the Etame Marin block offshore Gabon.Socket Mobile (SCKT) +39% on contactless reader clearing Google Wallet Certification.Micro Focus International (MFGP) +31%.Phoenix Tree Holdings (DNK) +2...

Chiasma (CHMA) perks 6% premarket after announcing positive top-line data from its global Phase 3 MPOWERED non-inferiority clinical trial comparing Mycapssa (oral octreotide capsules) to long-acting injectable somatostatin analogs (SSAs) for maintenance of biochemical response in pa...